L

01513

Livzon Pharmaceutical Group

26.65

-0.20-0.74%
Closed16:08 03/28 HKT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE26.750/26.850
TODAY RANGE26.600-27.250
VOL336.30K
MARKET CAP24.69B
52 WEEK RANGE21.500-30.150
AVG VOL (3M)615.93K
% TURNOVER0.04%
TURNOVER9.03M
P/E (TTM)11.305
% RANGE2.42%
EPS(TTM)2.357
P/E(FORWARD)11.584
P/B1.661
BVPS16.047
DIVIDEND1.744
P/S1.558
BETA--
DIV YIELD6.54%
FREE FLOAT MKT CAP8.26B
SHARES OUTSTANDING926.46M
NEXT EARNINGS--
FREE FLOAT309.83M
LOT SIZE100
EX-DIV DATE07/04/2023
Feeds
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

L

Livzon Pharmaceutical Group

01513

-0.74%
26.650

A

Amgen

04332

--

C

China Conch Venture Holdings

00586

+2.26%
5.440

W

Wuxi Apptec

02359

+0.68%
37.100

A

Asymchem Laboratories (Tianjin)

06821

+0.41%
61.500

S

Sinopharm Group

01099

-1.72%
20.050

G

Guangzhou Baiyunshan Pharmaceutical Holdings

00874

+0.10%
19.240

S

Shanghai Pharmaceuticals Holding

02607

-2.08%
11.300

S

Shanghai Fosun Pharmaceutical (Group)

02196

+0.63%
12.800

C

China Medical System Holdings

00867

-34.45%
8.220

S

SciClone Pharmaceuticals (Holdings)

06600

0.00%
16.040

W

Wuxi Biologics (Cayman)

02269

+3.92%
14.300

C

China Isotope & Radiation

01763

-9.82%
10.100

C

China Shineway Pharmaceutical Group

02877

-2.01%
9.730

T

The United Laboratories International Holdings

03933

-3.03%
8.960

C

Consun Pharmaceutical Group

01681

-3.11%
5.600

3

3SBio

01530

+4.18%
5.980

S

Shandong Xinhua Pharmaceutical

00719

+1.70%
5.380

B

Beijing Tong Ren Tang Chinese Medicine

03613

+0.11%
8.950

C

China Resources Pharmaceutical Group

03320

-1.77%
5.000

C

CSPC Pharmaceutical Group

01093

-1.91%
6.150
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.